Protocolo de indicación y administración de inmunosupresión y terapias biológicas en las enfermedades pulmonares intersticiales

Díaz, 2008, Mecanismos de acción de los fármacos inmunosupresores, Revista Chilena de Reumatología., 24, 73 Ancochea, 2010, Consensus on the diagnosis of idiopathic interstitial pneumonia, Arch Bronconeumol., 46Suppl5, 1, 10.1016/S0300-2896(10)70033-8 Olivieri, 2000, Interstitial lung diseases, European Respiratory Monograph, 5 2002, International multisdiciplinary consensus classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med., 165, 277, 10.1164/ajrccm.165.2.ats01 Paramothayan, 2002, Corticosteroid therapy in pulmonary sarcoidosis a systematic review, JAMA, 287, 1301, 10.1001/jama.287.10.1301 Richeldi, 2003, Corticosteroids for idiopathic pulmonaryf ibrosis, Cochrane Database Syst Rev., 3, 10.1002/14651858.CD002880 Raghu, 2012, Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis, N Engl J Med., 366, 1968, 10.1056/NEJMoa1113354 Meyer, 2014, Immunosuppressive agents and interstitial lung disease: what are the risks, Expert Rev Respir Med., 8, 263, 10.1586/17476348.2014.880054 Galofré, 2009, Manejo de los corticoides en la práctica clínica, Rev Med Univ Navarra., 53, 9 Baughman, 2012, Executive summary: monitoring of non esteroid a limmunosuppresive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines, Chest., 142, 1284, 10.1378/chest.12-1075 Marder, 2007, Advances in immunosuppressive therapy, Semin Respir Crit Care Med., 28, 398, 10.1055/s-2007-985612 Tashkin, 2006, Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med., 354, 2655, 10.1056/NEJMoa055120 Tashkin, 2007, Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease, Am J Respir Crit Care Med., 176, 1026, 10.1164/rccm.200702-326OC Hoyles, 2006, A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma, Arthritis Rheum., 54, 3962, 10.1002/art.22204 Maher, 2014, Immunosuppression for connective tissue disease-related pulmonary disease, Semin Respir Crit Care Med., 35, 265, 10.1055/s-0034-1371531 Daoussis, 2012, Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuses sytemic sclerosis, Clin Exp Rheumatol., 30, S17